Is this small cap a good ASX growth share?

With today's news, is National Veterinary Care Ltd (ASX:NVL) an exciting ASX growth option?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

National Veterinary Care Ltd (ASX: NVL) has announced some news today that may excite some investors, although the share price is currently down 2%.

This morning the veterinary business told investors that it has entered into a binding agreement to acquire two more veterinary clinics in New Zealand. There are a few conditions, but settlements are expected to take place within the next month.

The new clinics are close to other National Veterinary Care clinics in New Zealand and are expected to deliver total annual revenue of approximately NZ$3.65 million and total annual earnings before interest and tax (EBIT) of approximately NZ$0.76 million.

National Vet Care revealed that the total acquisition cost will be NZ$3.94 million, with a NZ$3.25 million payment upfront.

The company's managing director Tomas Steenackers said "Following our acquisition of Pet Doctors group in New Zealand late last year, these acquisitions will complement our New Zealand presence in key areas and will be supported by the existing operations team that was established at the time Pet Doctors was acquired."

If these two clinics are acquired it will bring National Veterinary Care's total network across Australia and New Zealand to 99 clinics.

It is certainly catching up to Greencross in terms of total clinic numbers, but only time will tell which veterinary business will be the largest in five years.

Foolish takeaway

I do think that National Vet Care can grow to at least 150 clinics, if not 200 or more, so there is scope for continued growth. However, in recent months I'm not as excited about the potential long-term shareholder returns.

The FY19 and perhaps FY20 results are likely to show impressive growth, but after that the ongoing organic revenue growth of existing clinics may remain at around 3% or less, so I would only want to hold it for a few years to try to outperform the market during the acquisition phase rather than owning it for a couple of decades or longer.

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of NATVETCARE FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrid day on the markets.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Energy Shares

5 ASX 200 energy shares smash multi-year highs after oil price spike

The ASX 200 Energy Index reached a two-year high of 11,071.80 points on Thursday.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Share Market News

ASX 200 down as fresh missile strikes on energy assets send oil prices higher

The Brent crude oil price jumped 4% to US$112 per barrel today.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: What this leading broker is saying about Lynas shares

Is it bullish or bearish? Let's find out.

Read more »

share buyers, investors, happy investors
Broker Notes

Bell Potter's top ASX 200 holdings revealed

These are the top holdings in the broker's core portfolio.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Broker Notes

Up 139% in a year, why this buy rated ASX All Ords rare earths stock could keep racing higher

A leading broker forecasts more outperformance to come from this surging ASX rare earths stock.

Read more »

Business women working from home with stock market chart showing per cent change on her laptop screen.
52-Week Lows

CSL and these ASX 200 stocks just hit 52-week lows: Should you buy the dip?

Market volatility has pushed a number of high-quality stocks lower. Here’s how I’m thinking about this.

Read more »

Miner with thumbs up at a mine.
Gold

2 ASX gold miners to buy for solid share price gains, according to Barrenjoey

The Africa-focused companies are deeply undervalued after recent sell-offs, the broker says.

Read more »